SRTS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SRTS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sensus Healthcare's quarterly accounts payable & accrued expense increased from Jun. 2023 ($3.94 Mil) to Sep. 2023 ($4.00 Mil) but then declined from Sep. 2023 ($4.00 Mil) to Dec. 2023 ($2.83 Mil).
Sensus Healthcare's annual accounts payable & accrued expense increased from Dec. 2021 ($4.06 Mil) to Dec. 2022 ($6.41 Mil) but then declined from Dec. 2022 ($6.41 Mil) to Dec. 2023 ($2.83 Mil).
The historical data trend for Sensus Healthcare's Accounts Payable & Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sensus Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accounts Payable & Accrued Expense | Get a 7-Day Free Trial | 4.78 | 2.87 | 4.06 | 6.41 | 2.83 |
Sensus Healthcare Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Accounts Payable & Accrued Expense | Get a 7-Day Free Trial | 6.41 | 4.93 | 3.94 | 4.00 | 2.83 |
Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
Joseph C Sardano | director, officer: Chief Executive Officer | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Michael Sardano | officer: GENERAL COUNSEL | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
John Heinrich | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Samuel O'rear | director | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Magdalena Martinez | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Emiliano Sosa | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
William H Mccall | director | 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487 |
Nicolas Soro | officer: Chief Operating Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Javier Rampolla | officer: Chief Financial Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Stephen Brad Cohen | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
Megan Cornish | director | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Yonatan Vainer | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Russ Price | officer: Chief Technology Officer | 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487 |
Kalman Fishman | officer: CHIEF TECHNOLOGY OFFICER | 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487 |
Richard Golin | officer: EXECUTIVE VICE PRESIDENT | 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487 |
From GuruFocus
By Stock market mentor Stock market mentor • 01-09-2023
By sperokesalga sperokesalga • 03-17-2023
By Marketwired • 07-25-2023
By sperokesalga sperokesalga • 05-17-2023
By sperokesalga sperokesalga • 06-15-2023
By PurpleRose PurpleRose • 07-20-2022
By sperokesalga sperokesalga • 04-25-2023
By PurpleRose PurpleRose • 07-26-2022
By GuruFocusNews GuruFocusNews • 06-22-2022
By GlobeNewswire GlobeNewswire • 10-20-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.